Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine

Vaccine

Volumn 28, Issue 16, 2010, Pages 2860-2864

  Chaves, Sandra S ^a   Groeger, Justina ^a   Helgenberger, Louisa ^b   Auerbach, Steven B ^c   Bialek, Stephanie R ^a   Hu, Dale J ^a   Drobeniuc, Jan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Federated States of Micronesia   (Federated States of Micronesia)

^c HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

Author keywords

Anamnestic response; Hepatitis B vaccination; Hepatitis B virus; Long term immunity

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; DRUG RESPONSE; HEPATITIS B; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; CHILD, PRESCHOOL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; MALE;

EID: 77949872694     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.01.059     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1. Immunization of infants, children, and adolescents. MMWR Recomm Rep 54 RR-16 (2005) 1-31
2. Banatvala J., Van Damme P., and Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 19 (2000) 877-885
3. Petersen K.M., Bulkow L.R., McMahon B.J., Zanis C., Getty M., Peters H., et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 23 (2004) 650-655
4. Lee S.S., Young B.W., Wong K.H., and Lim W.L. The implication of a reduced-dose hepatitis B vaccination schedule in low risk newborns. Vaccine 20 (2002) 3752-3754
5. Dentinger C.M., McMahon B.J., Butler J.C., Dunaway C.E., Zanis C.L., Bulkow L.R., et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 24 (2005) 786-792
6. Zanetti A.R., Mariano A., Romanò L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 (2005) 1379-1384
7. Samandari T., Fiore A.E., Negus S., Williams J.L., Kuhnert W., McMahon B.J., et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 120 (2007) e373-e381
8. Hammitt L.L., Hennessy T.W., Fiore A.E., Zanis C., Hummel K.B., Dunaway E., et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 25 (2007) 6958-6964
9. Taiwan study 15 years f/up and CMI.
10. Bialek S.R., Bower W.A., Novak R., Helgenberger L., Auerbach S.B., Williams I.T., et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 27 October (10) (2008) 881-885
11. Mahoney F.J., Woodruff B.A., Erben J.J., Coleman P.J., Reid E.C., Schatz G.C., et al. Progress on the elimination of hepatitis B virus transmission in Micronesia and American Samoa. Pac Health Dialog 3 (1996) 140-146
12. Dentico P., Crovari P., Lai P.L., Ponzio F., Safary A., Pellegrino A., et al. Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. Vaccine 20 November (31-32) (2002) 3725-3730
13. McMahon B.J., Dentinger C.M., Bruden D., Zanis C., Peters H., Hurlburt D., et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 200 November (9) (2009) 1390-1396
14. Zanetti A.R., Mariano A., Romanò L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 October (9494) (2005) 1379-1384
15. Gabbuti A., Romanò L., Blanc P., Meacci F., Amendola A., Mele A., et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 25 April (16) (2007) 3129-3132 Epub 2007 Jan 19
16. Williams I.T., Goldstein S.T., Tufa J., Tauillii S., Margolis H.S., and Mahoney F.J. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 22 (2003) 157-163
17. Patel P., Armstrong G., Samandari T., Talekar S., Yamanguchi K., Kuhnert W., et al. Long term effectiveness of hepatitis B vaccine in Palau. Presented at: abstracts of the infectious diseases society of American 43rd annual meeting (2004) Abstract
18. Wu J.S., Hwang L.Y., Goodman K.J., Beasley R.P., and Hepatitis. B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 179 June (6) (1999) 1319-1325
19. van der Sande M.A., Waight P.A., Mendy M., Zaman S., Kaye S., Sam O., et al. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One 2 August (1) (2007) e753
20. Walz A., Wirth S., Hucke J., and Gerner P. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen. J Infect Dis 200 October (8) (2009) 1227-1231